메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Millennium Technology Prize opens its nomination period f…

HELSINKI, Nov. 6, 2025 -- The world's leading innovation award, Millennium Technology Prize, will be awarded again in May 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and stimulate further research and development. The global call for nominations will be open for groundbreaking innovations between 6 November 2025 and 27 February 2026. The Millennium Technology Prize is the pre-eminent one-million-euro award focused on technological innovations for a better life. The winnin
- 김갑성 기자
- 2025-11-06 16:15
Leading Fertility Specialist Associate Professor Gavin Sacks…

SYDNEY, Nov. 6, 2025 -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate Professor Gavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition of clinical leadership excellence. Dr Sacks brings over 20 years of experience at the forefront of reproductive medicine and is recognised globally for his groundbreaking research in reproductive medicine including luteinising hormone (LH) supplementation, innovative stimulation protocols, genomic screenin
- 김갑성 기자
- 2025-11-06 16:09
KT&G sees record quarterly revenue and operating profit in…

Quarterly global cigarette revenue surpasses KRW 500 billion for the first time; cigarette& NGP performs solidly hand-in-hand Acquires ASF jointly with Altria, modern product's global expansion to gain momentum SEOUL, South Korea, Nov. 6, 2025 -- KT&G (KRX: 033780) presented its simultaneous achievement of record-high quarterly revenue and operating profit based on core business competitiveness and profitability-focused growth strategy, announcing its according upward adjustment of yearly guidance during an earnings call held on the 6th. KT&a
- 김갑성 기자
- 2025-11-06 15:49
International Symposium on Myofunctional Therapy Conclu…

SHANGHAI, Nov. 5, 2025 -- The International Symposium on Myofunctional Therapy in Multidisciplinary Collaboration, hosted by the Chinese Association of Orofacial Myology (CHAOM) and supported by Smartee Denti-Technology, concluded successfully in Shanghai. The event brought together leading clinicians, educators, and researchers from China and the United States to examine the evolving role of orofacial myofunctional therapy (OMT) in contemporary orthodontic practice. OMT Gains Ground as a Critical Component of Orthodontic Diagnostics and Treatment Planning Keynote speake
- 김갑성 기자
- 2025-11-06 15:35
Lunai Bioworks achieves complete regression of both prim…

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both primary and metastatic pancreatic tumors in humanized mouse models. The study was published in a new Brief Report in Vaccines on November 2, 2025. The peer-reviewed Brief Report details the develo
- 김갑성 기자
- 2025-11-06 14:11
THE ADECCO GROUP Q3 2025 RESULTS

AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 -- HIGHLIGHTS Further strong market share gains, Group +375 bps and Adecco +300 bps Group revenues +3.4% yoy, and +3.0% qoq, with all GBUs improving sequentially Adecco GBU revenues +4.5% yoy; Europe returned to growth; Americas +20% yoy, APAC +9% yoy Akkodis GBU revenues -3% yoy; German turnaround progressing well LHH GBU revenues +4% yoy, led by CT +9% yoy, Ezra +59% yoy Healthy 1
- 김갑성 기자
- 2025-11-06 13:45
Alphamab Oncology Showcases Cutting-edge Breakthroug…

SUZHOU, China, Nov. 6, 2025 -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-payload ADC", showcasing the company's cutting-edge technological breakthroughs and innovative achievements in the ADC field to a global audience. The modularly designed dual-payload ADC platform technology and the prominent preclinical efficacy of JSKN021 garnered attention from attendees, making it on
- 김갑성 기자
- 2025-11-06 12:05
The 2025 Chinese Congress on Holistic Integrative Oncolog…

KUNMING, China, Nov. 6, 2025 -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the World Association of Integrative Oncology (WAIO) and the China Institute of Integrative Medicine Development Strategy, and jointly organized by Yunnan Cancer Hospital, Kunming Medical University and Yunnan Anti-Cancer Association, this congress aims to become a significant milestone for academic exchang
- 김갑성 기자
- 2025-11-06 10:58
New Regional Certifications to Boost Healthcare Training Stan…

Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 -- The first healthcare simulation certification programmes designed specifically for Southeast Asian professionals were launched at the S3 Conference 2025 opening ceremony today. The event was attended by Mr Tan Kiat How, Senior Minister of State, Ministry of Digital Development and Information & Ministry of Health. The Certified Educator in Healthcare Simulation (CEHS) and Certified T
- 김갑성 기자
- 2025-11-06 10:13
Ispire Technology Inc.、2026年度第1四半期決算電話会議の開催を予定

ロサンゼルス, 2025年11月6日 -- 電子タバコ技術と精密投与の先駆者であるIspire Technology Inc.（以下「Ispire」または「同社」）（NASDAQ：ISPR）は本日、2025年9月30日に終了した第1四半期の決算結果について説明するため、2025年11月6日（木曜）午前8時（米国東部時間）より決算電話会議を開催することを発表しました。決算電話会議を聞くには、下記の番号でダイヤル・インしてください。ダイヤル・イン時に案内があった場合は、「Ispire Technology Call」とお申し出ください。開催日：2025年11月6日（木曜）時間：午前8時中央ヨーロッパ時間（ET）ダイヤル・イン番号：米国内からは 844-826-3033、海外からは +1-412-317-5185 におかけください。この電話会議はウェブキャストでライブ配信され、関係者全員が以下からアクセスできます：https://viavid.webcasts.com/starthere.jsp?ei=1738889&tp_key=82f919c8ba。通話開始の少なくとも15分前までにリンクにアクセスして登録の上、必要なオーディオ・ソフトウェアをダウンロード、インストールしてください。&n
- 김갑성 기자
- 2025-11-06 09:54

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-11-06_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 06일 18시 40분